<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="10.17917/DM9W-8430 " scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><h2>NCL Method ITA-25: Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Human IFNÅ’? in Culture Supernatants</h2><hr><p>IFNg is type II interferon produced by lymphocytes (T-cells, NK cells, NKT cells) in response to viral infections and inflammatory stimuli, including but not limited to bacterial lipopolysaccharide LPS and CpG DNA. Factors mitogenic to T-cells (e.g. PHA-M) can also induce this interferon. IFNg is essential in maintaining function of adaptive immunity through regulation of T cell function. It is also important for protection from intracellular bacteria (e.g. M.tuberculosis) and anti-tumor immunity. This document describes experimental procedure for analysis of culture supernatants by ELISA to detect presence of IFNg. NCL protocol ITA-10 should be referred to for details of preparation of culture supernatants.</p><h3>File name: protocols/20240411_13-48-46-802_NCL_Method_ITA-25.pdf</h3><h3>DOI: <a href = http://dx.doi.org/10.17917/DM9W-8430 >http://dx.doi.org/10.17917/DM9W-8430 </a></h3><h3>Resource Type:  Protocol</h3><h3>Data Access: <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a></h3></body></html>